117 related articles for article (PubMed ID: 6448065)
1. [Advantages and disadvantages of antipoliomyelitis vaccines prepared with live and killed viruses].
Melnick JL
Bol Oficina Sanit Panam; 1980 Jun; 88(6):507-29. PubMed ID: 6448065
[No Abstract] [Full Text] [Related]
2. [Advantages and inconveniences of inactive and live antipoliomyelitis vaccines].
Melnick JL
Bull World Health Organ; 1978; 56(5):677-98. PubMed ID: 310715
[No Abstract] [Full Text] [Related]
3. Advantages and disadvantages of killed and live poliomyelitis vaccines.
Melnick JL
Bull World Health Organ; 1978; 56(1):21-38. PubMed ID: 307445
[TBL] [Abstract][Full Text] [Related]
4. Decision analysis in planning for a polio outbreak in the United States.
Jenkins PC; Modlin JF
Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
[TBL] [Abstract][Full Text] [Related]
5. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine--supplementary statement.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1987 Dec; 36(48):795-8. PubMed ID: 3119980
[No Abstract] [Full Text] [Related]
6. [Epidemiology and control of poliomyelitis. II. Poliovirus vaccines].
Carrada-Bravo T
Bol Med Hosp Infant Mex; 1983 Nov; 40(11):604-12. PubMed ID: 6651947
[No Abstract] [Full Text] [Related]
7. Poliomyelitis vaccines: killed or live?
Br Med J; 1978 Sep; 2(6141):845-6. PubMed ID: 709087
[No Abstract] [Full Text] [Related]
8. Leads from the MMWR. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine--supplementary statement.
JAMA; 1988 Jan; 259(3):345-6. PubMed ID: 3336150
[No Abstract] [Full Text] [Related]
9. Poliomyelitis vaccines. Success and controversy.
LaForce FM
Infect Dis Clin North Am; 1990 Mar; 4(1):75-83. PubMed ID: 2407779
[TBL] [Abstract][Full Text] [Related]
10. Toward eradication of poliomyelitis by combined use of killed and live vaccines.
Melnick JL
Cardiovasc Res Cent Bull; 1982; 20(3):49-60. PubMed ID: 6805957
[No Abstract] [Full Text] [Related]
11. [Oral poliomyelitis vaccination: why should transmission of vaccine viruses to unvaccinated infants be avoided if possible?].
Wiersbitzky S
Kinderarztl Prax; 1993 May; 61(3):120-1. PubMed ID: 8392122
[No Abstract] [Full Text] [Related]
12. Apropos risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
Arya SC; Agarwal N
Expert Rev Vaccines; 2012 Nov; 11(11):1291. PubMed ID: 23249227
[TBL] [Abstract][Full Text] [Related]
13. [Poliomyelitis: new revelations, renewed polemics and the Hungarian experiences].
Dömök I
Orv Hetil; 1983 Jun; 124(23):1355-67. PubMed ID: 6877813
[No Abstract] [Full Text] [Related]
14. [Anti-poliomyelitis vaccination].
Cadrobbi P
G Mal Infett Parassit; 1970 Apr; 22(4):273-8. PubMed ID: 5515865
[No Abstract] [Full Text] [Related]
15. Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines.
Laassri M; Lottenbach K; Belshe R; Rennels M; Plotkin S; Chumakov K
J Infect Dis; 2006 May; 193(10):1344-9. PubMed ID: 16619180
[TBL] [Abstract][Full Text] [Related]
16. A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children.
Breiman RF; Brooks WA; Goswami D; Lagos R; Borja-Tabora C; Lanata CF; Londoño JA; Lum LC; Rappaport R; Razmpour A; Walker RE; Gruber WC; Forrest BD
Vaccine; 2009 Sep; 27(40):5472-9. PubMed ID: 19616493
[TBL] [Abstract][Full Text] [Related]
17. Poliomyelitis vaccines.
S Afr Med J; 1977 Nov; 52(22):868. PubMed ID: 607496
[No Abstract] [Full Text] [Related]
18. Infectious disease. Vaccine-related polio outbreak in Nigeria raises concerns.
Roberts L
Science; 2007 Sep; 317(5846):1842. PubMed ID: 17901301
[No Abstract] [Full Text] [Related]
19. Combined use of live and killed vaccines to control poliomyelitis in tropical areas.
Melnick JL
Dev Biol Stand; 1981; 47():265-73. PubMed ID: 7227655
[No Abstract] [Full Text] [Related]
20. Poliomyelitis prevention.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1982 Jan; 31(3):22-6, 31-4. PubMed ID: 6799765
[No Abstract] [Full Text] [Related]
[Next] [New Search]
